Related Experiment Video
Updated: Dec 9, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Tamoxifen Downregulates the Expression of Notch1 and DLL1 Genes in MKN-45 Gastric Cancer Cells
Faranak Khanipouyani1, Hassan Akrami2
1Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran.
Purpose:
Gastric cancer is one of the most prevalent cancers worldwide and the second most common cause for cancer associated mortality. Anti-tumor effects of tamoxifen in breast cancer are well-established. However, no study has so far investigated the effects of tamoxifen on gene expression of Notch1 and DLL1 in gastric cancer cell line. The present study was conducted to explore the effects of tamoxifen, as a repurposed drug, on gene expression of Notch1 and DLL1 in MKN-45, a gastric cancer cell line.
Methods:
MKN-45 cells were cultured in DMEM/F12 medium containing 10% FBS. Cytotoxic effects of tamoxifen on these cells at various concentrations were evaluated by trypan blue exclusion assay. For gene expression analysis, the cells were first incubated with 100 μM tamoxifen followed by total RNA extraction from treated and control cells. Then, cDNA was synthesized. Quantitative real-time PCR using specific primers for Notch1 and DLL1 was performed to assess the effect of tamoxifen on the transcript of them.
Results:
Treatment with tamoxifen decreased viability of MKN-45 cells in a dose-dependent manner. CC50 was estimated to be around 200 μM. Also, tamoxifen at the dose of 100 μM could significantly downregulate mRNA levels of both Notch1 and DLL1 genes as compared with untreated cells by 24% and 92%, respectively.
Conclusion:
Based on these results, tamoxifen interferes with Notch signaling pathway through downregulating the expression of Notch1 and DLL1 genes and this could be regarded as a mechanism for its anti-cancer effects in this malignant disease.
Insights
Tamoxifen, a repurposed drug, was found to downregulate Notch1 and DLL1 gene expression in gastric cancer cells. This suggests a potential mechanism for tamoxifen's anti-cancer effects in this disease.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Gastric cancer is a leading cause of cancer mortality globally.
- Tamoxifen is known for its anti-tumor effects in breast cancer.
- The impact of tamoxifen on Notch signaling in gastric cancer remains unexplored.
Purpose of the Study:
- To investigate the effects of tamoxifen on Notch1 and DLL1 gene expression in the MKN-45 gastric cancer cell line.
- To explore tamoxifen as a potential repurposed drug for gastric cancer treatment.
Main Methods:
- MKN-45 cells were treated with varying concentrations of tamoxifen.
- Cell viability was assessed using the trypan blue exclusion assay.
- Quantitative real-time PCR was employed to measure Notch1 and DLL1 mRNA levels post-treatment.
Main Results:
- Tamoxifen exhibited dose-dependent cytotoxicity against MKN-45 cells, with a CC50 of approximately 200 μM.
- A 100 μM dose of tamoxifen significantly downregulated Notch1 mRNA by 24% and DLL1 mRNA by 92% compared to controls.
Conclusions:
- Tamoxifen interferes with the Notch signaling pathway in gastric cancer cells.
- Downregulation of Notch1 and DLL1 gene expression by tamoxifen may contribute to its anti-cancer activity in gastric cancer.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Angiogenesis and Blood Supply
MicroRNAs
MicroRNAs

